Neural Regeneration Research, 2022 · DOI: 10.4103/1673-5374.338993 · Published: April 1, 2022
Following spinal cord injury (SCI), functional recovery is extremely limited in adult mammals. This lack of recovery is reflective of the collective failure of lesioned axons to re-grow and damaged neurons to regenerate in the spinal cord following the primary trauma. In contrast to the devastating consequence of spinal cord injury in mammals, several non-mammalian species within the vertebrate subphylum have a much higher regenerative capacity within the central nervous system (CNS) and can undergo functional recovery in adulthood. One evolutionarily conserved family of signaling factors involved in various aspects of secondary responses to injury in both regenerative and non-regenerative species is the purinergic signaling system.
Understanding the purinergic system's role in spinal cord injury could lead to novel therapeutic interventions.
Studying regeneratively competent species provides an opportunity to elucidate critical pro-regenerative pathways.
Therapeutic approaches could target the endogenous progenitor potential of spinal ependymal cells and functional axonal regeneration.